JUPITER-02 Phase III Global Study of Toripalimab at the Interim Analysis Met Pre-Specified Primary Endpoint of Progression-Free Survival in Recurrent or Metastatic Nasopharyngeal Carcinoma
Nulla a velit quis ex ornare rhoncus. Donec imperdiet risus justo, vel malesuada erat fermentum at. Morbi at laoreet mauris.…
